+ All Categories
Home > Documents > ncm 102 tantan

ncm 102 tantan

Date post: 10-Apr-2018
Category:
Upload: tantanbarago
View: 219 times
Download: 0 times
Share this document with a friend

of 109

Transcript
  • 8/8/2019 ncm 102 tantan

    1/109

    NURSINGMANAGEMENT

    OFGIT

    PROBLEMS

    GASTRIC ANDDUODENALDISORDERS

  • 8/8/2019 ncm 102 tantan

    2/109

    GASTRITIS

    Inflammation of the gastric mucosa. Often caused by dietary indiscretion or misuse

    of

    gastric irritating medications (aspirin, NSAIDs),

    excessive alcohol intake, bile reflux and radiation

    therapy.

    Chronic gastritis and prolonged inflammation of

    the stomach may be caused by either benign or

    malignant ulcers of the stomach, or by the

    bacteria Helicobacter pylori.

  • 8/8/2019 ncm 102 tantan

    3/109

    GASTRITIS

    The gastric mucous membrane becomes edematous and hyperemic and undergoes

    superficial erosion.

    Gastric mucosa secretes a scanty amount of

    gastric juice, containing normal amount of

    acid,

    but very little mucus, and superficial erosions

    may occur and can lead to hemorrhage.

  • 8/8/2019 ncm 102 tantan

    4/109

    GASTRITIS

    Clinical Manifestations: Abdominal discomfort

    Headache, lassitude

    Nausea, anorexia Vomiting

    Singultus

    Pyrosis

    Belching

    Sour taste in the mouth

  • 8/8/2019 ncm 102 tantan

    5/109

    GASTRITIS

    Diagnosis can be obtained by endoscopy,upper

    GI radiographic studies, and histologic

    examination of a tissue specimen obtained by

    biopsy.

    In addition to biopsy, other diagnosticmeasures

    for detecting H. pylori include serologic testing

    for antibodies against H. pylori antigen.

  • 8/8/2019 ncm 102 tantan

    6/109

    GASTRITIS

  • 8/8/2019 ncm 102 tantan

    7/109

    GASTRITIS

  • 8/8/2019 ncm 102 tantan

    8/109

    GASTRITIS

    Medical Management:Refrain from alcohol and food untilsymptoms subsideNon-irritating dietFluids may need to be administeredparenterallyCommon antacids to neutralize acidsEmetics and lavage are avoided because ofthe danger of perforation and damage to theesophagus.

  • 8/8/2019 ncm 102 tantan

    9/109

    GASTRITIS

    Medical Management:

    Nasogastric intubation

    Analgesic agents and sedatives

    Fiberoptic endoscopy may be necessary

    Emergency surgery to remove gangrenous or

    perforated tissue

    Diet modification

    H. pylori may be treated with antibiotics and a

    proton-pump inhibitor and possibly bismuth salts

  • 8/8/2019 ncm 102 tantan

    10/109

    GASTRITIS

    Nursing Management:

    Assessment

    Nursing Diagnoses

    Planning and Goals

    Nursing Interventions:

    1. Reducing anxiety

    2. Promoting optimal nutrition

    3. Promoting fluid balance

    4. Relieving pain

    Promoting home and community-based care

  • 8/8/2019 ncm 102 tantan

    11/109

    GASTRIC AND DUODENAL ULCERS

    A peptic ulcer is an excavation that forms in the

    mucosal wall of the stomach, in the pylorus, in

    the duodenum, or in the esophagus.

    Peptic ulcers are more likely to be in the

    duodenum than in the stomach.

    As a result, gastric ulcers tend to occur alone, but

    they may occur in multiples.

    Chronic gastric ulcers tend to occur in the lesser

    curvature of the stomach, near the pylorus.

  • 8/8/2019 ncm 102 tantan

    12/109

    GASTRIC AND DUODENAL ULCERS

    Peptic ulcer disease occurs with the greatest

    frequency in people between the ages of 40 and

    60 years.

    In the past, stress and anxiety were thought to be

    causes of ulcers.

    Familial tendency may be a significant

    predisposing factor.

    People with blood type O are more susceptible to

    peptic ulcers than are those with blood type A, B,

    or AB.

  • 8/8/2019 ncm 102 tantan

    13/109

    GASTRIC AND DUODENAL ULCERS

    Microbiologic etiology: Helicobacter pylori

    Other predisposing factors: chronic NSAID

    intake, alcohol ingestion, and excessive smoking.

    Rarely ulcers are caused by excessive amounts of

    the hormone gastrin, produced by tumors

    (Zollinger-Ellison syndrome): severe peptic

    ulcers, extreme gastric hyperacidity, and gastrinsecreting

    benign or malignant tumors of the

    pancreas.

  • 8/8/2019 ncm 102 tantan

    14/109

    GASTRIC AND DUODENAL ULCERSDUODENAL ULCER GASTRIC ULCER

    AGE 30 60 years Usually 50 and over

    MALE:FEMALE RATIO 2-3:1 1:1

    INCIDENCE 80% of peptic ulcers 15% of peptic ulcers

    STOMACH ACID Hypersecretion Normal or hyposecretion

    BODY WEIGHT Normal or weight gain Weight loss

    EPIGASTRIC PAIN 2-3 hrs post-meal, early

    morning awakenings,

    relieved by food intake

    - 1 hr post-meal, rarely

    occurs at night; food intake

    aggravates pain

    VOMITING Uncommon Common (relieves pain)

    HEMORRHAGE Less common, melena More common,hematemesis

    PERFORATION More common Less common

    MALIGNANCY Rare Occasionally

    RISK FACTORS H. Pylori, alcohol,

    smoking, cirrhosis, stress

    H. pylori, gastritis, alcohol,

    smoking, NSAIDs, stress

  • 8/8/2019 ncm 102 tantan

    15/109

    GASTRIC AND DUODENAL ULCERS:

    Pathophysiology

    Peptic ulcers occur mainly in the gastroduodenal

    mucosa because this tissue cannot withstand the

    digestive action of gastric acid and pepsin.

    Erosion is caused by increased concentration or

    activity of acid pepsin, or by decreased resistance

    of the mucosa.

    The use of NSAIDs inhibits the secretion of

    mucus that protects the mucosa.

  • 8/8/2019 ncm 102 tantan

    16/109

    GASTRIC AND DUODENAL ULCERS:

    Pathophysiology

    Stress ulcer is the term given to the acute

    mucosal ulceration of the duodenal or gastric area

    that occurs after physiologically stressful events,

    such as burns, shock, severe sepsis and multiple

    organ traumas.

    As the stressful condition continues, the ulcers

    spread. When the patient recovers, the lesions

    are reversed.

  • 8/8/2019 ncm 102 tantan

    17/109

    GASTRIC AND DUODENAL ULCERS:

    Pathophysiology

    Cushings ulcers are common in patients with

    trauma to the brain. They may occur in the

    esophagus, stomach or duodenum and are usually

    deeper and more penetrating than stress ulcers.

    Curlings ulcers are frequently observed about 72

    hours after extensive burns and involves the

    antrum of the stomach or the duodenum.

  • 8/8/2019 ncm 102 tantan

    18/109

    GASTRIC AND DUODENAL ULCERS:

    Assessment

    Endoscopy is the preferred diagnostic procedure

    because it allows direct visualization of

    inflammatory changes, ulcers and lesions.

    Stools may be tested periodically until they are

    negative for occult blood.

    H. pylori infection may be determined by biopsy

    and histology with culture, as well as a breath test

    and serologic test for H. pylori antibodies.

  • 8/8/2019 ncm 102 tantan

    19/109

    GASTRIC AND DUODENAL ULCERS:

    Assessment

  • 8/8/2019 ncm 102 tantan

    20/109

    GASTRIC AND DUODENAL ULCERS:

    Assessment

  • 8/8/2019 ncm 102 tantan

    21/109

    Medical Management:

    Once the diagnosis is established, the patient is

    informed that the problem can be controlled.

    Recurrence may develop; however, peptic ulcers

    treated with antibiotics to eradicate H. pylori

    have a lower recurrence rate than those not

    treated with antibiotics.

    Methods include medications, lifestyle

    modification, and surgical intervention.

  • 8/8/2019 ncm 102 tantan

    22/109

    Medical Management: Pharmacologic

    Therapy

    Most commonly used therapy is a combination of

    antibiotics, proton pump inhibitors, and bismuth

    salts that suppresses or eradicates H. pylori.

    Histamine-2 (H2) receptor antagonists and proton

    pump inhibitors are used to treat NSAID-induced

    and other ulcers not associated with H. pylori

    ulcers.

    Patient is advised to adhere to the medication

    regimen to ensure complete healing of the ulcer.

  • 8/8/2019 ncm 102 tantan

    23/109

    Medical Management: Stress

    Reduction and Test

    Reducing environmental stress requires physical

    and psychological modifications on the patients

    part as well as the aid and cooperation of family

    members and significant others.

    Identify situations that are stressful and

    exhausting.

    Biofeedback, hypnosis (?), or behavior

    modification may be helpful.

  • 8/8/2019 ncm 102 tantan

    24/109

    Medical Management:

    Smoking Cessation

    Studies have shown that smoking decreases the

    secretion of bicarbonate from the pancreas into

    the duodenum, resulting in increased acidity of

    the duodenum.

    Patient is strongly encouraged to stop smoking.

  • 8/8/2019 ncm 102 tantan

    25/109

    Medical Management:

    Dietary Modification

    The intent is to avoid oversecretion of acid and

    hypermotility of the GI tract.

    Avoiding extremes of temperature and

    overstimulation from consumption of meat

    extracts, alcohol, coffee (including decaffeinated

    coffee) and other caffeinated beverages, and diets

    rich in milk and cream.

    Neutralize acid by eating three regular meals a

    day.

  • 8/8/2019 ncm 102 tantan

    26/109

    Surgical Management

    Surgery is usually recommended for patients with

    intractable ulcers (those that fail to heal after 12

    to 16 weeks of medical treatment), lifethreatening

    hemorrhage, perforation, or

    obstruction, and for those with ZES that do not

    respond to medications.

    Vagotomy, with or without pyloroplasty.

    Billroth I (gastroduodenostomy) and Billroth II

    (gastrojejunostomy) procedures.

  • 8/8/2019 ncm 102 tantan

    27/109

    Follow-Up Care

    Recurrence within a year may be prevented with

    the prophylactic use of H2-receptor antagonists

    given at a reduced dose. Not all patients require

    maintenance therapy.

    Likelihood of recurrence is reduced if th4e

    patient avoids smoking, coffee and other

    caffeinated beverages, alcohol, and ulcerogenic

    medications.

  • 8/8/2019 ncm 102 tantan

    28/109

    Follow-Up Care

    Recurrence within a year may be prevented with

    the prophylactic use of H2-receptor antagonists

    given at a reduced dose. Not all patients require

    maintenance therapy.

    Likelihood of recurrence is reduced if th4e

    patient avoids smoking, coffee and other

    caffeinated beverages, alcohol, and ulcerogenic

    medications.

  • 8/8/2019 ncm 102 tantan

    29/109

    NURSINGMANAGEMENT

    OFGIT

    PROBLEMS

    INTESTINALAND RECTALDISORDERS

  • 8/8/2019 ncm 102 tantan

    30/109

    CONSTIPATION

    Abnormal infrequency or irregularity of

    defecation, abnormal hardening of the stools that

    makes their passage difficult and sometimes

    painful, a decrease in stool volume, or retention

    of stool in the rectum for a prolonged period.

    May be caused by certain medications, rectal or

    anal disorders, obstruction, metabolic, neurologic

    and neuromuscular conditions, endocrine

    disorders, lead poisoning and connective tissue

    disorders.

  • 8/8/2019 ncm 102 tantan

    31/109

    CONSTIPATION: Pathophysiology

    Poorly understood.

    Interference with mucosal transport, myoelectric

    activity, or processes of defecation.

  • 8/8/2019 ncm 102 tantan

    32/109

    CONSTIPATION: Clinical Manifestations

    Abdominal distention

    Borborygmus

    Pain and pressure

    Decreased appetite

    Headache, fatigue

    Indigestion

    Sensation of incomplete emptying

    Passage of scybala

  • 8/8/2019 ncm 102 tantan

    33/109

    CONSTIPATION: Assessment and

    Diagnosis

    Chronic constipation is usually considered

    idiopathic, but secondary causes should be

    eliminated.

    Diagnosis is based on results of the patients

    history, physical examination, possibly a barium

    enema or sigmoidoscopy, and stool testing for

    occult blood.

  • 8/8/2019 ncm 102 tantan

    34/109

    CONSTIPATION: Assessment and

    Diagnosis

    Chronic constipation is usually considered

    idiopathic, but secondary causes should be

    eliminated.

    Diagnosis is based on results of the patients

    history, physical examination, possibly a barium

    enema or sigmoidoscopy, and stool testing for

    occult blood.

  • 8/8/2019 ncm 102 tantan

    35/109

    CONSTIPATION: Complications

    Hypertension

    Fecal impaction

    Hemorrhoids and fissures

    Megacolon

  • 8/8/2019 ncm 102 tantan

    36/109

    CONSTIPATION: Medical Management

    Treatment is aimed at the underlying cause of

    constipation and includes education, bowel habit

    training, increased fiber and fluid intake, and

    judicious use of laxatives.

    Enemas and rectal suppositories are generally not

    recommended for constipation and should be

    reserved for the treatment of impaction or for

    preparing the bowel for surgery or diagnostic

    procedures.

  • 8/8/2019 ncm 102 tantan

    37/109

    CONSTIPATION: Medical Management

    Further studies are being carried out on

    cholinergic agents (e.g., bethanechol),

    cholinesterase inhibitors (e.g., neostigmine), and

    prokinetic agents (e.g., metoclopramide) to

    determine the role of these agents in treating

    constipation.

  • 8/8/2019 ncm 102 tantan

    38/109

    CONSTIPATION: Nursing Management

    Elicit information about the onset and duration of

    constipation, past and present elimination

    patterns, the patients expectation of normal

    bowel elimination, and lifestyle information

    during health history review.

    Past medical and surgical history, current

    medications, and laxative and enema use are

    important, as is information about the sensation

    of rectal fullness or pressure, abdominal pain,

    excessive straining at defecation and flatulence.

  • 8/8/2019 ncm 102 tantan

    39/109

    CONSTIPATION: Nursing Management

    Patient education and health promotion

    Restoring and maintaining a regular pattern of

    elimination

    Ensuring adequate intake of fluids and high-fiber

    foods

    Teach methods to avoid constipation

    Relieve anxiety about bowel elimination patterns

    Avoid complications

  • 8/8/2019 ncm 102 tantan

    40/109

    DIARRHEA

    Increased frequency of bowel movements (more

    than three per day), increased amount of stool

    volume (more than 200 g per day), and altered

    consistency (i.e., looseness) of stool.

    Associated with urgency, perianal discomfort,

    incontinence, or a combination of these factors.

    Caused by increased intestinal secretions,

    decreased mucosal absorption, or altered motility.

  • 8/8/2019 ncm 102 tantan

    41/109

    DIARRHEA

    Acute diarrhea is most often associated with

    infection, and is usually self-limiting.

    Chronic diarrhea persists for a longer period

    (three weeks), and may return sporadically.

    Diarrhea can be caused by certain medications,

    tube feeding formulas, metabolic and endocrinedisorders, viral or bacterial infectious processes,

    nutritional and malabsorptive disorders and anal

    sphincter defects.

  • 8/8/2019 ncm 102 tantan

    42/109

    DIARRHEA: Pathophysiology

    Types of diarrhea: secretory, osmotic and mixed

    diarrhea.

    Secretory diarrhea is usually high-volume

    diarrhea caused by increased production and

    secretion of water and electrolytes by the

    intestinal mucosa into the intestinal lumen. Osmotic diarrhea occurs when water is pulled

    into the intestines by the osmotic pressure of

    unabsorbed particles, slowing the reabsorption of

    water.

  • 8/8/2019 ncm 102 tantan

    43/109

    DIARRHEA: Pathophysiology

    Mixed diarrhea is caused by increased peristalsis

    (usually from IBD) and a combination of

    increased secretion and decreased absorption in

    the bowel.

  • 8/8/2019 ncm 102 tantan

    44/109

    DIARRHEA: Clinical Manifestations

    Increased frequency and fluid content of stools

    Abdominal cramps and distention

    Intestinal rumbling

    Anorexia and thirst

    Painful spasmodic contractions of the anus and

    ineffectual straining (tenesmus) Watery stools are characteristic of small bowel

    disease.

    Loose, semisolid stools are associated more often

    with disorders of the colon.

  • 8/8/2019 ncm 102 tantan

    45/109

    DIARRHEA: Clinical Manifestations

    Voluminous, greasy stools suggest intestinal

    malabsorption.

    Presence of mucus and pus suggests

    inflammatory enteritis or colitis.

  • 8/8/2019 ncm 102 tantan

    46/109

    DIARRHEA: Assessment and Diagnostic

    Findings

    Complete blood count

    Chemical profile

    Urinalysis

    Routine stool examination

    Stool examinations for parasitic or infectious

    organisms, bacterial toxins, blood, fat andelectrolytes.

    Barium enema may assist in identifying the

    cause.

  • 8/8/2019 ncm 102 tantan

    47/109

    DIARRHEA: Complications

    Fluid and electrolyte imbalance (cardiac

    dysrhythmias)

    Renal failure

    Multiorgan failure and death

  • 8/8/2019 ncm 102 tantan

    48/109

    DIARRHEA: Medical Management

    Primary management is directed at controlling

    symptoms, preventing complications, and

    eliminating or treating the underlying disease.

    Certain medications may reduce the severity of

    the diarrhea and treat the underlying disease.

  • 8/8/2019 ncm 102 tantan

    49/109

    DIARRHEA: Nursing Management

    Assess and monitor the characteristics and

    pattern of diarrhea.

    Encourage bed rest and intake of fluids and food

    low in bulk until the acute attack subsides.

    When food intake is tolerated, recommend a

    bland diet of semisolid and solid food. Avoid caffeine, carbonated beverages and very

    hot and very cold food.

    Restrict milk products, fat, whole-grain products,

    fresh fruits and vegetables for several days.

  • 8/8/2019 ncm 102 tantan

    50/109

    DIARRHEA: Nursing Management

    Administer antidiarrheal medications such as

    diphenoxylate (Lomotil) and loperamide

    (Imodium) as prescribed.

    IV therapy for rapid rehydration especially for

    the elderly and those with preexisting GI

    conditions. Monitor serum electrolyte levels

    Report immediately clinical evidence of

    dysrhythmias or a change in the level of

    consciousness.

  • 8/8/2019 ncm 102 tantan

    51/109

    DIARRHEA: Nursing Management

    The perianal area may be excoriated because

    diarrheal stool contains digestive enzymes that

    can irritate the skin. The patient should follow a

    perianal skin care routine to decrease irritation

    and excoriation.

    Use skin sealants and moisture barriers asneeded.

  • 8/8/2019 ncm 102 tantan

    52/109

    APPENDICITIS

    The most common cause of acute abdomen in the

    United States.

    Males > females

    Adolescents > adults

  • 8/8/2019 ncm 102 tantan

    53/109

  • 8/8/2019 ncm 102 tantan

    54/109

  • 8/8/2019 ncm 102 tantan

    55/109

    APPENDICITIS: Assessment and

    Diagnostic Findings

    Diagnosis is based on results of a complete

    physical examination and on laboratory and x-ray

    findings.

    Leukocytosis

    Localized distention of the bowel or RLQ density

    on abdominal x-ray films, sonographic ortomographic studies.

  • 8/8/2019 ncm 102 tantan

    56/109

    APPENDICITIS: Complications

    Perforation of the appendix

    Peritonitis

    Abscess

  • 8/8/2019 ncm 102 tantan

    57/109

    APPENDICITIS: Medical Management

    Surgery is indicated upon diagnosis.

    Antibiotics and intravenous fluids are

    administered until surgery is performed.

    Analgesics may be administered in some patients

    after the diagnosis is made.

    Appendectomy is performed as soon as possibleto decrease the risk of perforation.

  • 8/8/2019 ncm 102 tantan

    58/109

    APPENDICITIS: Nursing Management

    Palliative Preoperative Care

    Place patient in a comfortable position to relieve

    abdominal pain and tension usually Fowlers

    position.

    See that the patient takes nothing by mouth to

    decrease peristalsis and to allow stomach to emptypreparatory to surgery. Note time and nature of last

    meal.

    Place ice bag to right lower quadrant.

    Do not administer cathartics.

    Frequently evaluate vital signs.

  • 8/8/2019 ncm 102 tantan

    59/109

    APPENDICITIS: Nursing Management

    Operative

    If diagnosis is established, a simple appendectomy is

    performed.

    Because relief is almost assured, patient usually

    accepts surgery very willingly, which afford a smooth

    recovery. Anesthetic may be general or spinal.

    Incision may be McBurney, muscle splitting or gridiron,

    or right rectus.

  • 8/8/2019 ncm 102 tantan

    60/109

    APPENDICITIS: Nursing Management

    Postoperative Care

    Following recovery from anesthetic, Fowlers position

    is maintained, analgesic is given every 3 or 4 hours as

    needed, and fluids and food are given as tolerated.

    Stitches are removed between 5th and 7th day (usually

    in the physicians office).

  • 8/8/2019 ncm 102 tantan

    61/109

    APPENDICITIS: Nursing Management

    Goals: relieve pain, prevent fluid volume deficit,

    reduce anxiety, eliminate infection, maintain skin

    integrity, and attain optimal nutrition

    Prepare patient for surgery

    NGT insertion

    Avoid enema Post-operative care

    Instruction for wound care prior to discharge

  • 8/8/2019 ncm 102 tantan

    62/109

    APPENDICITIS: Nursing Management

    Goals: relieve pain, prevent fluid volume deficit,

    reduce anxiety, eliminate infection, maintain skin

    integrity, and attain optimal nutrition

    Prepare patient for surgery

    NGT insertion

    Avoid enema Post-operative care

    Instruction for wound care prior to discharge

  • 8/8/2019 ncm 102 tantan

    63/109

    INFLAMMATORY BOWEL DISEASE

    Refers to two chronic inflammatory GI disorders:

    regional enteritis (i.e., Crohns disease or

    granulomatous colitis) and ulcerative colitis.

    The cause is still unknown.

    Researchers think it is triggered by

    environmental agents such as pesticides, foodadditives, tobacco, and radiation.

    NSAIDs have been found to exacerbate IBD.

    Allergies and immune disorders have also been

    suggested as causes.

  • 8/8/2019 ncm 102 tantan

    64/109

  • 8/8/2019 ncm 102 tantan

    65/109

    INFLAMMATORY BOWEL DISEASE

    CROHNS DISEASE ULCERATIVE COLITIS

    COURSE Prolonged, variable Exacerbations, remissions

    EARLY PATHOLOGY Transmural thickening Mucosal ulceration

    LATE PATHOLOGY Deep, penetrating

    granulomas

    Mucosal minute ulcerations

    LOCATION Ileum, right colon (usually) Rectum, left colon

    BLEEDING Usually not, but may occur Common severe

    PERIANAL

    INVOLVEMENT

    Common Rare mild

    FISTULAS Common RareRECTAL

    INVOLVEMENT

    About 20% Almost 100%

    DIARRHEA Less severe Severe

  • 8/8/2019 ncm 102 tantan

    66/109

    INFLAMMATORY BOWEL DISEASE

    CROHNS DISEASE ULCERATIVE COLITIS

    RADIOGRAPHY Regional, discontinuous

    lesions

    Narrowing of colon

    Thickening of bowel wall

    Mucosal edemaStenosis, fistulas

    Diffuse involvement

    No narrowing of colon

    No mucosal edema

    Stenosis rare

    Shortening of colonAbnormal inflamed mucosa

    SIGMOIDOSCOPY May be unremarkable

    unless accompanied by

    perianal fistulas

    Abnormal inflammed

    mucosa

    COLONOSCOPY Distinct ulcerations

    separated by relatively

    normal mucosa in the

    right colon

    Friable mucosa with

    pseudopolypsor ulcers in

    the left colon

  • 8/8/2019 ncm 102 tantan

    67/109

  • 8/8/2019 ncm 102 tantan

    68/109

  • 8/8/2019 ncm 102 tantan

    69/109

    INFLAMMATORY BOWEL DISEASE

  • 8/8/2019 ncm 102 tantan

    70/109

    COLORECTAL CANCER

    The colorectal area is the third most common site

    of new cancer cases and deaths.

    Incidence increases with age and is higher for

    people with a family history of colon cancer and

    those with IBD or polyps.

    Risk factors:

    Increasing age

    Past and family history of colon cancer, polyps, IBD

    High-fat, high-protein, low-fiber diet

    Genital or breast cancer (in women)

  • 8/8/2019 ncm 102 tantan

    71/109

    COLORECTAL CANCER:

    Pathophysiology

    Predominantly (95%) adenocarcinoma.

    Usually starts as a benign polyp but may become

    malignant, invade and destroy normal tissues,

    and extend into surrounding structures.

    Cancer cells may break away from the primary

    tumor and spread to other parts of the body (most

    often the liver).

  • 8/8/2019 ncm 102 tantan

    72/109

    COLORECTAL CANCER:

    Clinical Manifestations

    Determined by the location of the cancer, the

    stage of the disease, and the function of the

    intestinal segment in which it is located.

    Change in bowel habits

    Passage of blood in the stools

    Unexplained anemia, anorexia, weight loss and

    fatigue

    Dull abdominal pain and melena (right colon)

    Abdominal pain, cramping, narrowing stools,

    constipation and distention (left colon)

  • 8/8/2019 ncm 102 tantan

    73/109

    COLORECTAL CANCER:

    Clinical Manifestations

    Tenesmus, rectal pain, feeling of incomplete

    evacuation after a bowel movement, alternating

    diarrhea and constipation and bloody stool (rectal

    lesions)

  • 8/8/2019 ncm 102 tantan

    74/109

    COLORECTAL CANCER:

    Assessment and Diagnosis

    Abdominal and rectal examination

    Fecal occult blood testing

    Barium enema

    Proctosigmoidoscopy and colonoscopy with

    biopsy or cytology smears

    CEA studies for prognostication

  • 8/8/2019 ncm 102 tantan

    75/109

    COLORECTAL CANCER:

    Assessment and Diagnosis

  • 8/8/2019 ncm 102 tantan

    76/109

    COLORECTAL CANCER:

    Assessment and Diagnosis

  • 8/8/2019 ncm 102 tantan

    77/109

  • 8/8/2019 ncm 102 tantan

    78/109

    COLORECTAL CANCER:

    Medical Management

    Depends on the stage of the disease

    Surgery to remove the tumor

    Supportive therapy

    Adjuvant therapy

    Chemotherapy

    Radiation therapy

    Immunotherapy

    Multimodality therapy

  • 8/8/2019 ncm 102 tantan

    79/109

  • 8/8/2019 ncm 102 tantan

    80/109

    ANORECTAL DISEASES:

    Hemorrhoids

    Dilated portions of veins in the anal canal

    Internal hemorrhoids vs external hemorrhoids

    Cause itching and pain and the most common

    cause of bright red bleeding with defecation

    Symptoms and discomfort can be relieved by

    good personal hygiene and by avoiding excessive

    straining during defecation.

    High residue diet that contains fruit and bran

    along with an increased fluid intake may be all

    the treatment that is necessary.

    A O C AL IS AS S

  • 8/8/2019 ncm 102 tantan

    81/109

    ANORECTAL DISEASES:

    Hemorrhoids

    Warm compresses, sitz baths, analgesic

    ointments and suppositories, astringents, and bed

    rest allow the engorgement to subside.

    Nonsurgical treatments: infrared

    photocoagulation, bipolar diathermy and laser

    therapy, sclerosing solutions

    Surgical treatment: rubber band ligation,

    cryosurgery, hemorrhoidectomy

  • 8/8/2019 ncm 102 tantan

    82/109

    NURSINGMANAGEMENT

    OFGIT

    PROBLEMS

    HEPATIC,BILLIARY

    SYSTEM ANDPANCREAS

  • 8/8/2019 ncm 102 tantan

    83/109

    HEPATITIS

    Hepatitis is an inflammation of the liver caused

    by a variety of factors; most infectious etiologies

    are viral in nature.

    Significance:

    From a community health perspective, one is

    concerned with ease of disease transmission and

    morbidity.

    From a socioeconomic viewpoint, one is concerned

    with prolonged loss of time from school and

    employment.

  • 8/8/2019 ncm 102 tantan

    84/109

  • 8/8/2019 ncm 102 tantan

    85/109

    HEPATITIS

  • 8/8/2019 ncm 102 tantan

    86/109

    HEPATITISHAV HBV HCV HDV HEV

    Incubation(days) 15-45,mean 30 30-180, mean60-90 15-160,mean 50 30-180,mean 60-90 14-60,mean 40

    Onset Acute Insidious or

    acute

    Insidious Insidious or

    acute

    Acute

    Age

    preference

    Children,

    young

    adults

    Young

    adults,

    babies,toddlers

    Any age,

    but more

    commonin adults

    Any age

    (similar to

    HBV)

    Young

    adults

    (20-40years)

    Transmission Fecal-

    oral

    Percutaneous

    Perinatal

    Sexual

    Similar to

    HBV

    Similar to

    HBV

    Fecal-oral

    Severity Mild Occasionallysevere Moderate Occasionallysevere Mild

    Fulminant 0.1% 0.1-1% 0.1% 5-20% 1-2%

    Progression to

    chronicity

    None Occasional (1-

    10%, 90%

    of neonates)

    Common Common None

    HEPATITIS

  • 8/8/2019 ncm 102 tantan

    87/109

    HEPATITIS

    HAV HBV HCV HDV HEV

    Carrier None 0.1-30% 0.5-1% Variable None

    Cancer None + (neonatal

    infection)

    + + or - None

    Prognosis Excellent Worse with

    age, debility

    Moderate Acute, Good

    Chronic,

    poor

    Good

    Prophylaxis IG

    vaccine

    HBIG

    Recombinant

    vaccine

    None HBV vaccine

    (none for

    HBV

    carriers)

    Unknown

    Therapy None Interferon

    40% effective

    Interferon

    50%

    response;

    sustained

    response

    < 15%

    Unknown None

  • 8/8/2019 ncm 102 tantan

    88/109

    HEPATITIS A

    Epidemiology

    RNA virus of the enterovirus family

    Mode of transmission:

    Feca-oral route; respiratory route possible

    Poor sanitation; person-to-person (epidemic type)

    Contaminated food, milk, polluted water, or shell fish

    Blood transfusion rarely

    Incubation: 3 to 7 weeks; average 4 weeks

    Occurrence:

    Worldwide

    Usually children and young adults

  • 8/8/2019 ncm 102 tantan

    89/109

    HEPATITIS B

    Epidemiology

    Double-shelled virus containing DNA

    Causative agent is composed of:

    Antigenic material in an outer coat hepatitis B surface

    antigen (HBsAg)

    Antigenic material in an inner coat hepatitis B core antigen

    (HBcAg)

    An independent protein circulating in the blood (HBeAg)

    Antibody:

    Anti-HBs produced early after infection

    Anti-HBc noted later in convalescence

    Anti-Hbe noted later in convalescence

  • 8/8/2019 ncm 102 tantan

    90/109

    HEPATITIS B

    Epidemiology

    Double-shelled virus containing DNA

    Causative agent is composed of:

    Antigenic material in an outer coat hepatitis B surface

    antigen (HBsAg)

    Antigenic material in an inner coat hepatitis B core antigen

    (HBcAg)

    An independent protein circulating in the blood (HBeAg)

    Antibody:

    Anti-HBs produced early after infection

    Anti-HBc noted later in convalescence

    Anti-Hbe noted later in convalescence

    HEPATITIS B

  • 8/8/2019 ncm 102 tantan

    91/109

    HEPATITIS BCOMMONLY ENCOUNTERED SEROLOGIC PATTERNS OF HEPATITIS B INFECTION

    HBsAg Anti-HBs Anti-HBc HB-eAG Anti-HBe Interpretation

    + - IgM + - Acute HBV infection, high

    infectivity

    + - IgG + - Chronic HBV infection, high

    infectivity

    + - IgG - + Late-acute or chronic HBVinfection, low infectivity

    + + + + or - + or - 1. HBsAg of one

    subtype and

    heterotypic anti-

    HBs (common)

    2. Process ofseroconversion

    - - IgM + or - + or - 1. Acute HBV

    infection

    2. Anti-HBc window

  • 8/8/2019 ncm 102 tantan

    92/109

  • 8/8/2019 ncm 102 tantan

    93/109

    HEPATITIS B

    Epidemiology

    Mode of transmission:

    Oral-oral via saliva

    Parenterally or via intimate contact with carriers

    Male homosexuals

    Blood, saliva, semen, vaginal secretions

    Incubation: 2 to 5 months

    Occurrence: affects all ages but mostly young adults

    worldwide

  • 8/8/2019 ncm 102 tantan

    94/109

    HEPATITIS B

    Assessment

    Resembles Hepatitis A clinically.

    Symptoms insidious and variable.

    Arthralgias and rashes may be observed; fever and

    respiratory symptoms are rare.

    Jaundice may or may not be present.

    Anorexia, abdominal pain, generalized ailing, malaise

    may be noted.

  • 8/8/2019 ncm 102 tantan

    95/109

    HEPATITIS B

    Nursing Management

    Provide adequate fluids, nutrition and bed rest.

    Administer alkalis, belladonna and antiemetics if

    these agents are required to control dyspepsia and

    malaise.

    A newly available gamma globulin with a high titer of

    anti HBs seems to reduce severity of hepatitis

    following needle-stick exposure or contact.

    Recognize that recovery and convalescence are slow

    and prolonged, sometimes taking 3 to 4 months;

    provide psychosocial stimulation.

    Hepatitis vaccination

  • 8/8/2019 ncm 102 tantan

    96/109

    HEPATITIS CIRRHOSIS

    Cirrhosis of the liver is a chronic disease in

    which there has been diffuse destruction of

    parenchymal cells followed by degeneration and

    increase in connective tissue.

    Classification:

    Laennecs cirrhosis alcoholic

    Postnecrotic

    Biliary

    Posthepatitic

  • 8/8/2019 ncm 102 tantan

    97/109

    HEPATITIS CIRRHOSIS

    Nursing Management

    Instruct and prepare patient for the very many

    laboratory studies.

    Evaluate nutritional status and needs.

    Monitor intake and output accurately.

    Adjust nutritional offerings if the patient has ascites

    and edema.

    Assist the patient in overcoming anorexia, weight loss

    and fatigue.

    Observe skin and control pruritus.

  • 8/8/2019 ncm 102 tantan

    98/109

    HEPATITIS CIRRHOSIS

    Nursing Management

    Recognize the effect of esthetic factors.

    Eliminate alcohol but encourage high caloric intake.

    Give supplementary vitamins.

    Be cognizant of signs of hematemesis and melena.

    Anticipate manifestations of hemorrhage.

    Recognize signs of increasing stupor.

    Health education

  • 8/8/2019 ncm 102 tantan

    99/109

    HEPATITIS ENCEPALOPATHY

    Nursing Management

    Recognize the effect of esthetic factors.

    Eliminate alcohol but encourage high caloric intake.

    Give supplementary vitamins.

    Be cognizant of signs of hematemesis and melena.

    Anticipate manifestations of hemorrhage.

    Recognize signs of increasing stupor.

    Health education

  • 8/8/2019 ncm 102 tantan

    100/109

    HEPATITIS ENCEPALOPATHY

    Precipitating Factors

    Progressive hepatocellular disease

    Increased sources of ammonia in the blood

    Infections, paracentesis, acute alcoholism,

    hypotension, shock, general anesthesia, minor

    surgery, hypokalemia, alkalosis, administration of

    sedatives or narcotics.

    Portocaval shunts

  • 8/8/2019 ncm 102 tantan

    101/109

  • 8/8/2019 ncm 102 tantan

    102/109

    HEPATITIS ENCEPALOPATHY

    Nursing Management

    Evaluate the patients vital functions.

    Arrest gastrointestinal bleeding and reduce

    intraintestinal nitrogen.

    Reduce and possibly eliminate all sedatives and

    analgesics.Administer only those specifically

    prescribed.

    Prevent complications.

  • 8/8/2019 ncm 102 tantan

    103/109

    GALLBLADDER DISEASE

    Types

    Cholecystitis (inflammation of the gall bladder)

    Cholelithiasis (stones in the gall bladder)

    Choledocholithiasis (stones in the common bile duct)

    Assessment and Clinical Manifestations

    History of episodic and usually colicky epigastric or

    RUQ pain associated with nausea and vomiting.

    Jaundice (?)

    Murphys sign

  • 8/8/2019 ncm 102 tantan

    104/109

    GALLBLADDER DISEASE

    Treatment

    Surgery is advised if gallstones are present.

    In older patients, the risk of surgery must be evaluated

    in relation to other disease conditions present.

    Chenodeoxycholic acid can decrease the size of an

    existing stone and prevent new stones from forming.

    For acute cholecystitis, provide hospitalization, bed

    rest, withholding of oral fluids, and insertion of

    nasogastric tube with suction.

    Administer IV fluids to correct electrolyte imbalances,

    maintain adequate UO and provide nutritional needs.

  • 8/8/2019 ncm 102 tantan

    105/109

    GALLBLADDER DISEASE

    Treatment

    Administer medication for pain and infection control.

    Prepare for laboratory studies.

    Record vital signs every 4 hours and prepare for

    surgery.

  • 8/8/2019 ncm 102 tantan

    106/109

    ACUTE PANCREATITIS

    Acute pancreatitis is an inflammation of the

    pancreas brought about by the digestion of this

    organ by enzymes.

    Etiology

    Unknown

    Associated with excessive intake of alcohol

    Associated with blockage of the ampulla of Vater by

    gallstones

    Associated with spasm and edema of the ampulla of

    Vater following duodenitis or after treatment with

    opiates.

  • 8/8/2019 ncm 102 tantan

    107/109

    ACUTE PANCREATITIS

    Etiology

    May occur as a complication of mumps or bacterial

    disease.

    Some congenital hyperlipidemias appear to be related

    to acute pancreatitis.

    Clinical Manifestations

    Abdominal and back pain

    Nausea, vomiting and fever

    Tenderness across upper abdomen often minimal

    Elevated lipase and amylase

  • 8/8/2019 ncm 102 tantan

    108/109

    ACUTE PANCREATITIS

    Nursing Management

    Relieve discomfort and pain to control restlessness

    Give meperidine (Demerol)

    Encourage patient to assume position of comfort

    Decrease pancreatic secretions by reducing

    stimulation

    NPO

    Anticholinergic medications

    NGT insertion

    Maintain comfort of the intubated patient

  • 8/8/2019 ncm 102 tantan

    109/109

    ACUTE PANCREATITIS

    Nursing Management

    Monitor patient for signs of respiratory failure.

    Provide medications to correct deficiencies and

    prevent complications

    Parenteral fluids, electrolytes, blood and plasma; accurate I

    and O.

    Antimicrobials

    Control of hyperglycemia

    Support cardiopulmonary system

    Surgical intervention (controversial)

    Health education and discharge planning


Recommended